Rat tendon, rodent muscle, mouse cardiac and keratinocyte culture models, read strictly as models. No human data is discussed. Research use only.
What the compounds are
Three materials appear in the model literature surveyed here. BPC-157 is a pentadecapeptide of 15 residues, sequence GEPPPGKPADDAGLV, formula C62H98N16O22, molecular weight 1419.50 g/mol, CAS number 137525-51-0. TB-500 is the acetylated heptapeptide Ac-LKKTETQ, residues 17 to 23 of thymosin beta-4, formula C38H68N10O14, and the animal studies below used full-length thymosin beta-4 rather than that fragment. KPV is the tripeptide Lys-Pro-Val, corresponding to residues 11 to 13 of alpha-melanocyte stimulating hormone, and it is one component of the KLOW blend.
All compounds discussed are supplied strictly as laboratory research materials. They are not for human or veterinary use, and nothing here is medical advice. This article discusses no human data. Every study named below was carried out in rats, in mice or in cultured cells, the model is named in each case, and nothing here describes an outcome in a person or is intended to be read as guidance of any kind.
The research question
Injury models exist because a defined, reproducible lesion can be measured. In a rat Achilles tendon transection model the tendon is cut and repaired under a fixed protocol, then assessed histologically and mechanically. In a mouse cardiac ischaemia model the injury is surgical and the assessment is histological. In a keratinocyte culture model the insult is applied to a cell monolayer and the readout is an apoptosis or signalling assay. The published question in each case is whether a treated group differs from a control group on those measured variables inside that model.
This article describes those models and their measured variables and stops there. It does not rank the compounds, does not identify any of them as suited to a purpose outside a laboratory, and reports no human endpoint, because no human endpoint exists in the studies cited.
Rat tendon models
The most directly comparative study in this group tested BPC-157 and TB-500 in a rat Achilles tendon healing model and assessed the tendons histopathologically and biomechanically (PMID 42542926). Two features of that rat model design are worth naming: histopathology and mechanical testing measure different properties of the same rat tendon, so a difference in one need not appear in the other, and testing both compounds in one rat experiment removes the between-study variation that makes separate rat studies hard to compare.
A broader review of BPC-157 in musculoskeletal soft tissue collects the rodent tendon, ligament and muscle preparations used across that literature and describes what each animal model measured (PMID 30915550). For background on the tendon models themselves, independent of any compound, a review of tendon injury biology and repair sets out how experimental tendon lesions are made and scored in animal work and why those scoring systems behave as they do (PMID 25734975).
Mechanical testing in the rat tendon model is the endpoint most often misread. A load-to-failure or stiffness value from a rat tendon depends on the cross-sectional area of that tendon, on how the specimen was gripped and on the loading rate used, so two rat studies reporting tendon strength are comparable only when those parameters match. Histology on the same rat tendons measures tissue organisation rather than load, which is why a rat model that reports both can show a difference in one and not the other without contradiction.
Rodent muscle and gastrointestinal models
A second review examines BPC-157 across striated, smooth and cardiac muscle preparations in animals, grouping the rodent experiments by muscle type and describing the injury model used in each (PMID 36551977). Grouping by tissue is useful in a laboratory context because a rodent skeletal muscle crush model, a rodent smooth muscle preparation and a rodent cardiac model share almost no methodology beyond the compound tested.
The wider wound-healing review for the same compound covers the rodent skin, gastrointestinal and soft tissue models together and describes the animal preparations used across that corpus (PMID 34267654). Both are secondary sources. Their function here is to map which animal models exist and what was measured in each, not to supply evidence of their own, and neither contains a human model.
Mouse cardiac injury models
The thymosin beta-4 work in this area is cardiac and is carried out in mice. One study examined the time window for mammalian heart regeneration in a mouse model, treating the window itself as the measured variable rather than a single endpoint at a fixed day (PMID 25284727). A later mouse study measured cardiac regeneration after ischaemic injury with thymosin beta-4 and prothymosin alpha, using histological and functional assessments in the mouse hearts (PMID 36125329).
A review of the cardiac literature collects those mouse experiments and the protective effects reported in the heart across the animal models used (PMID 30063857). As with the tendon literature, the material tested in these mouse studies is the full-length polypeptide, not the seven-residue fragment supplied as TB-500, and results from one do not transfer to the other without a study that tested the fragment.
The mouse cardiac models differ from the rat tendon models in a way that matters for reading them together. A mouse cardiac injury model measures regeneration through histological assessment of mouse heart tissue and through functional imaging of the mouse heart, on a timeline set by the mouse injury protocol. A rat tendon model measures a mechanical property of rat tissue at a fixed day after transection. The two rodent literatures share a vocabulary of repair but almost no methodology, and a claim assembled by combining them is a claim neither animal model made.
Keratinocyte culture models for KPV
KPV appears in this survey through a cell-culture study rather than an animal study. Cultured keratinocytes were exposed to fine dust particulate as the insult, and the measured variables were apoptosis, inflammatory markers, oxidative stress readouts and activity in the MAPK and NF-kappa B signalling pathways (PMID 40073467). That is a monolayer experiment with one insult and a defined marker panel.
Read as a model, its scope is narrow by design: it reports what a cultured keratinocyte population did under one stressor, which is a cell-culture measurement and not a tissue measurement, an animal measurement or a human measurement. KPV is supplied within the KLOW blend, and the composition of that blend is described on its own catalogue pages.
Limits of the evidence
Every study above is preclinical. The subjects are rats, mice and cultured cells; the endpoints are histological scores, mechanical test values, marker panels and cell-culture assays. Group sizes in the rodent work are small, several of the sources are reviews rather than primary experiments, and much of the corpus for each compound originates from a limited number of laboratories.
Three specific gaps deserve naming. The animal thymosin beta-4 studies used the parent polypeptide rather than the supplied fragment. The KPV evidence here is a single cell-culture study. And no study cited compares these materials against each other outside the one rat tendon experiment that tested two of them together. No human data is discussed anywhere in this article, no comparison here identifies any material as preferable for any purpose, and nothing above extrapolates beyond the animal and cell models named.
One more gap belongs in this list. The keratinocyte study is a monolayer experiment with a single particulate insult, so it reports what a cultured cell population did under that one stressor and nothing beyond it. There is no animal model for KPV among the studies cited here, which means the cell-culture result stands alone and has no rodent counterpart in this survey to be checked against. Saying so plainly is more useful to a laboratory than presenting the three materials as though their evidence bases were comparable, because they are not.
Related materials in the catalogue
Product pages are BPC-157, TB-500 and the KLOW peptide blend, with compound guides at the BPC-157 research guide, the TB-500 research guide and the KLOW blend research guide. All three are listed under tissue repair. Deeper mechanism articles are available for BPC-157 in tissue-repair research and thymosin beta-4 in wound models.
Analytical documentation for each lot is published under certificates, the reconstitution calculator converts a target concentration and vial mass into a solvent volume, and the analytical background is covered in how to verify a peptide certificate of analysis, HPLC peptide purity, mass spectrometry peptide testing and what a 99 percent purity figure means. All compounds discussed are supplied strictly as laboratory research materials. They are not for human or veterinary use, and nothing here is medical advice.
References
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in pharmacology, 2021. PMID 34267654
- Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. Biomedicines, 2022. PMID 36551977
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and tissue research, 2019. PMID 30915550
- Extending the time window of mammalian heart regeneration by thymosin beta 4. Journal of cellular and molecular medicine, 2014. PMID 25284727
- Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice. Cardiovascular research, 2023. PMID 36125329
- Thymosin β4-mediated protective effects in the heart. Expert opinion on biological therapy, 2018. PMID 30063857
- Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Tissue & cell, 2025. PMID 40073467
- Tendon injury: from biology to tendon repair. Nature reviews. Rheumatology, 2015. PMID 25734975
Research use only